Lovejoy B, Welch A R, Carr S, Luong C, Broka C, Hendricks R T, Campbell J A, Walker K A, Martin R, Van Wart H, Browner M F
Inflammatory Diseases Unit, Roche Bioscience, Palo Alto, California 94304, USA.
Nat Struct Biol. 1999 Mar;6(3):217-21. doi: 10.1038/6657.
The X-ray crystal structures of the catalytic domain of human collagenase-3 (MMP-13) and collagenase-1 (MMP-1) with bound inhibitors provides a basis for understanding the selectivity profile of a novel series of matrix metalloprotease (MMP) inhibitors. Differences in the relative size and shape of the MMP S1' pockets suggest that this pocket is a critical determinant of MMP inhibitor selectivity. The collagenase-3 S1' pocket is long and open, easily accommodating large P1' groups, such as diphenylether. In contrast, the collagenase-1 S1' pocket must undergo a conformational change to accommodate comparable P1' groups. The selectivity of the diphenylether series of inhibitors for collagenase-3 is largely determined by their affinity for the preformed S1' pocket of collagenase-3, as compared to the induced fit in collagenase-1.
人胶原酶-3(基质金属蛋白酶-13,MMP-13)和胶原酶-1(MMP-1)催化结构域与结合抑制剂的X射线晶体结构为理解一系列新型基质金属蛋白酶(MMP)抑制剂的选择性概况提供了基础。MMP S1'口袋相对大小和形状的差异表明,该口袋是MMP抑制剂选择性的关键决定因素。胶原酶-3的S1'口袋长且开放,易于容纳大的P1'基团,如二苯醚。相比之下,胶原酶-1的S1'口袋必须经历构象变化才能容纳类似的P1'基团。与胶原酶-1中诱导契合相比,二苯醚系列抑制剂对胶原酶-3的选择性很大程度上取决于它们对胶原酶-3预先形成的S1'口袋的亲和力。